Free Trial
→ Read this or regret it forever (From Porter & Company) (Ad)tc pixel Free ANEB Stock Alerts

Anebulo Pharmaceuticals (ANEB) Short Interest Ratio & Short Volume

Anebulo Pharmaceuticals logo
$0.46 -0.06 (-11.54%)
As of 01:41 PM Eastern
Compare

Anebulo Pharmaceuticals Short Interest Overview

As of February 27, 2026, Anebulo Pharmaceuticals (ANEB) had a short interest of 140,018 shares sold short, representing 1.77% of the public float. This marks a -4.34% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.2, meaning it would take 1.2 days of the average trading volume of 53,520 shares to cover all short positions.

Current Short Interest
140,018 shares
Previous Short Interest
146,372 shares
Change Vs. Previous Month
-4.34%
Dollar Volume Sold Short
$50.41 thousand
Short Interest Ratio
1.2 Days to Cover
Last Record Date
February 27, 2026
Outstanding Shares
40,785,000 shares
Short Percent of Float
1.77%
Today's Trading Volume
813 shares
Average Trading Volume
53,520 shares
Today's Volume Vs. Average
2%
Short Selling Anebulo Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ANEB Short Interest Over Time

ANEB Days to Cover Over Time

ANEB Percentage of Float Shorted Over Time

Anebulo Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/27/2026140,018 shares $50.41 thousand -4.3%1.8%1.16 $0.36
2/13/2026146,372 shares $70.11 thousand +188.8%1.9%1.17 $0.48
1/30/202650,692 shares $53.23 thousand -12.7%0.6%0.72 $1.05
1/15/202658,049 shares $60.38 thousand -15.5%0.7%1.52 $1.04
12/31/202568,730 shares $69.42 thousand -41.3%0.9%0.35 $1.01
12/15/2025117,022 shares $253.94 thousand -3.6%1.5%10.63 $2.17
11/28/2025121,417 shares $284.12 thousand +4.1%1.5%5.51 $2.34
11/14/2025116,684 shares $266.04 thousand -28.6%1.5%6.07 $2.28
10/31/2025163,504 shares $426.42 thousand -10.8%2.1%9.6 $2.61
10/15/2025183,300 shares $498.58 thousand -6.8%0.8%1.8 $2.72
9/30/2025196,700 shares $491.75 thousand -51.4%0.8%0.5 $2.50
9/15/2025404,300 shares $994.58 thousand -10.8%1.7%1 $2.46
8/31/2025453,000 shares $1.13 million +8.8%1.9%1.2 $2.50
8/15/2025416,300 shares $1.04 million -3.9%1.7%1.1 $2.50
7/31/2025433,300 shares $1.16 million +878.1%1.8%1.2 $2.67
7/15/202544,300 shares $69.55 thousand +20.7%0.2%0.1 $1.57
6/30/202536,700 shares $52.85 thousand +5.5%0.2%2.3 $1.44
6/15/202534,800 shares $48.37 thousand +11.2%0.1%2.6 $1.39
5/31/202531,300 shares $31.30 thousand -7.4%0.1%1.2 $1.00
5/15/202533,800 shares $34.14 thousand +0.6%0.1%1.3 $1.01
4/30/202533,600 shares $40.66 thousand -26.3%0.1%1.3 $1.21
4/15/202545,600 shares $43.32 thousand +62.9%0.2%1.7 $0.95
3/31/202528,000 shares $36.40 thousand -48.8%0.1%1.1 $1.30
3/15/202554,700 shares $93.54 thousand -12.3%0.2%1.3 $1.71
2/28/202562,400 shares $72.38 thousand -6.7%0.3%1.9 $1.16
2/15/202566,900 shares $88.98 thousand +2.1%0.3%2.3 $1.33
1/31/202565,500 shares $101.85 thousand -24.9%0.3%2.3 $1.56
1/15/202587,200 shares $144.32 thousand +42.0%0.4%3.2 $1.66
12/31/202461,400 shares $103.15 thousand +2,174.1%0.7%2.4 $1.68
12/15/20242,700 shares $3.78 thousand -57.8%0.0%0.1 $1.40
11/30/20246,400 shares $9.22 thousand -1.5%0.1%0.7 $1.44
11/15/20246,500 shares $10.32 thousand -39.8%0.1%0.7 $1.59
10/31/202410,800 shares $20.30 thousand -6.9%0.1%1.3 $1.88
10/15/202411,600 shares $22.04 thousand -20.0%0.1%1.6 $1.90
9/30/202414,500 shares $27.99 thousand -19.4%0.2%1.9 $1.93
9/15/202418,000 shares $37.44 thousand +27.7%0.2%2.3 $2.08
8/31/202414,100 shares $27.07 thousand +12.8%0.2%2.4 $1.92
8/15/202412,500 shares $24.25 thousand -5.3%0.1%2.3 $1.94
7/31/202413,200 shares $31.68 thousand -8.3%0.1%2.1 $2.40
7/15/202414,400 shares $34.85 thousand +15.2%0.2%2.1 $2.42
Read this or regret it forever (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
6/30/202412,500 shares $34.13 thousand +13.6%0.1%1.7 $2.73
6/15/202411,000 shares $23.10 thousand +4.8%0.1%1.5 $2.10
5/31/202410,500 shares $21.53 thousand +69.4%0.1%2 $2.05
5/15/20246,200 shares $14.57 thousand -65.4%0.1%1.1 $2.35
4/30/202417,900 shares $51.91 thousand -11.0%0.2%3.2 $2.90
4/15/202420,100 shares $59.50 thousand +6.9%0.2%3.6 $2.96
3/31/202418,800 shares $53.96 thousand +308.7%0.2%3.4 $2.87
3/15/20244,600 shares $11.68 thousand +39.4%0.1%0.5 $2.54
2/29/20243,300 shares $8.98 thousand +10.0%0.0%0.4 $2.72
2/15/20243,000 shares $8.25 thousand +11.1%0.0%0.3 $2.75
1/31/20242,700 shares $6.95 thousand -18.2%0.1%0.2 $2.58
1/15/20243,300 shares $7.95 thousand -10.8%0.2%0.2 $2.41
12/31/20233,700 shares $8.95 thousand -14.0%0.2%0.2 $2.42
12/15/20234,300 shares $8.43 thousand +30.3%0.2%0.2 $1.96
11/30/20233,300 shares $7.52 thousand +32.0%0.2%0.2 $2.28
11/15/20232,500 shares $5.58 thousand -56.1%0.1%0.1 $2.23
10/31/20235,700 shares $12.54 thousand -52.5%0.3%0.4 $2.20
10/15/202312,000 shares $29.52 thousand +55.8%0.4%0.9 $2.46
9/30/20237,700 shares $23.52 thousand -44.6%0.3%1.2 $3.06
9/15/202313,900 shares $44.48 thousand +1,444.4%0.5%2.2 $3.20
8/31/2023900 shares $2.51 thousand -35.7%0.0%0.1 $2.79
8/15/20231,400 shares $4.07 thousand -41.7%0.1%0.3 $2.91
7/31/20232,400 shares $5.18 thousand -7.7%0.1%0.7 $2.16
7/15/20232,600 shares $6.53 thousand +271.4%0.1%0.9 $2.51
6/30/2023700 shares $1.65 thousand +40.0%0.0%0.2 $2.35
6/15/2023500 shares $1.13 thousand +25.0%0.0%0.1 $2.25
5/31/2023400 shares $904.00 -91.7%0.0%0.1 $2.26
5/15/20234,800 shares $11.16 thousand -18.6%0.1%1.4 $2.33
4/30/20235,900 shares $17.23 thousand -9.2%0.1%1.6 $2.92
4/15/20236,500 shares $18.14 thousand -22.6%0.1%1.4 $2.79
3/31/20238,400 shares $24.36 thousand +460.0%0.2%1.6 $2.90
3/15/20231,500 shares $3.77 thousand -94.0%0.0%0.3 $2.51
2/28/202324,900 shares $76.69 thousand +6.4%0.5%4.3 $3.08
2/15/202323,400 shares $71.63 thousand -19.9%0.5%3.6 $3.06
1/31/202329,200 shares $74.46 thousand -24.4%0.6%3.8 $2.55
1/15/202338,600 shares $122.74 thousand +0.3%0.8%5.4 $3.18
12/30/202238,500 shares $93.31 thousand +1.3%0.8%5.1 $2.42
12/15/202238,000 shares $104.88 thousand +49.6%0.8%4.5 $2.76
11/30/202225,400 shares $55.88 thousand -5.6%0.6%3.3 $2.20
11/15/202226,900 shares $67.79 thousand -9.4%0.6%4.1 $2.52
10/31/202229,700 shares $71.58 thousand +29.7%1.3%3.1 $2.41
10/15/202222,900 shares $61.83 thousand +9.1%1.0%2.3 $2.70
9/30/202221,000 shares $58.80 thousand +78.0%0.9%2.1 $2.80
9/15/202211,800 shares $44.96 thousand +35.6%0.5%0.6 $3.81
8/31/20228,700 shares $30.19 thousand -71.7%0.4%0.5 $3.47
8/15/202230,700 shares $117.89 thousand +192.4%1.3%1.5 $3.84
7/31/202210,500 shares $31.34 thousand -33.1%0.5%0.6 $2.99
7/15/202215,700 shares $48.67 thousand -13.7%0.7%1 $3.10
6/30/202218,200 shares $94.64 thousand +1,720.0%0.8%1 $5.20
6/15/20221,000 shares $3.17 thousand -28.6%0.0%0.1 $3.17
Read this or regret it forever (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
5/31/20221,400 shares $3.78 thousand No Change0.1%0.2 $2.70
5/15/20221,400 shares $4.37 thousand +250.0%0.1%0.2 $3.12
4/30/2022400 shares $1.48 thousand No Change0.0%0.1 $3.71
4/15/2022400 shares $2.18 thousand -50.0%0.0%0.1 $5.46
3/31/2022800 shares $5.66 thousand -60.0%0.0%0.3 $7.08
3/15/20222,000 shares $13.54 thousand -20.0%0.1%1 $6.77
2/28/20222,500 shares $18.23 thousand No Change0.1%1.1 $7.29
2/15/20222,500 shares $16.65 thousand +13.6%0.1%0.8 $6.66
1/31/20222,200 shares $14.54 thousand -35.3%0.1%0.6 $6.61
1/15/20223,400 shares $23.45 thousand +41.7%0.2%0.8 $6.90
12/31/20212,400 shares $14.76 thousand -22.6%0.1%0.5 $6.15
12/15/20213,100 shares $19.53 thousand -54.4%0.1%0.7 $6.30
11/30/20216,800 shares $40.80 thousand -2.9%0.3%1.3 $6.00
11/15/20217,000 shares $45.78 thousand +16.7%0.3%1.7 $6.54
10/29/20216,000 shares $39.90 thousand -35.5%0.3%1.5 $6.65
10/15/20219,300 shares $66.77 thousand +66.1%0.4%2.7 $7.18
9/30/20215,600 shares $36.68 thousand -34.9%0.2%1.6 $6.55
9/15/20218,600 shares $59.56 thousand +59.3%0.4%2.1 $6.93
8/31/20215,400 shares $36.45 thousand -21.7%0.2%0.7 $6.75
8/13/20216,900 shares $48.15 thousand No Change0.3%0.6 $6.98

ANEB Short Interest - Frequently Asked Questions

Short interest is the volume of Anebulo Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 27th, traders have sold 140,018 shares of ANEB short. 1.77% of Anebulo Pharmaceuticals' shares are currently sold short. Learn More on Anebulo Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANEB shares currently have a short interest ratio of 1.2. Learn More on Anebulo Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.77% of Anebulo Pharmaceuticals' floating shares are currently sold short.

Anebulo Pharmaceuticals saw a decrease in short interest in February. As of February 27th, there was short interest totaling 140,018 shares, a decrease of 4.3% from the previous total of 146,372 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.77% of Anebulo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anebulo Pharmaceuticals: MediciNova, Inc. (0.41%), Actuate Therapeutics, Inc. (9.51%), Cassava Sciences, Inc. (14.86%), TScan Therapeutics, Inc. (1.63%), OKYO Pharma Limited Sponsored ADR (1.09%), Cingulate Inc. (12.76%), Prima BioMed Ltd (4.38%), iBio, Inc. (9.72%), BeyondSpring Inc. (7.53%), ImageneBio, Inc. (4.69%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.24 billion), Invesco QQQ ($35.39 billion), iShares Russell 2000 ETF ($20.89 billion), iShares 20+ Year Treasury Bond ETF ($11.45 billion), SPDR S&P Biotech ETF ($9.76 billion), Western Digital Corporation ($8.36 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.22 billion), Lumentum Holdings Inc. ($7.64 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.75 billion), and Financial Select Sector SPDR Fund ($6.13 billion). View all of the most shorted stocks.

Short selling ANEB is an investing strategy that aims to generate trading profit from Anebulo Pharmaceuticals as its price is falling. ANEB shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Anebulo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANEB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANEB, twice per month. The most recent reporting period available is February, 27 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ANEB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ANEB) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely, LLC | Sponsoredtc pixel